The Chemestmed team has returned from three productive and inspiring days at BIO-Europe in Vienna, where our representatives, Sigrid Selberg and Mati Karelson engaged with a wide network of industry experts, innovators, and partners from across the biotech landscape.
Chemestmed was pleased to take part in a recent delegation of Estonian HealthTech innovators in London.
Chemestmed is proud to announce a new research collaboration with FutureNeuro, the Research Ireland Centre for Translational Brain Science, and the research team led by Dr. Gary Brennan at University College Dublin.
Chemestmed and Tehistark have secured €150,000 funding from the Estonian Business and Innovation Agency to develop and test an AI-powered platform for preparing Investigational New Drug (IND) documentation. The collaboration aims to transform the regulatory submission process using experimental data from Chemestmed’s preclinical programs.
We are excited to welcome two new members to the Chemestmed team – Baiba Brumele and Juhan Pikamäe – who bring valuable experience and fresh perspectives to our research efforts.
Last week was packed with exciting events! While Chemestmed was represented at the RNA Leaders Congress in Basel, we also participated in the Maarjavälja Career Day at the University of Tartu on March 5th.
